X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ORCHID PHARMA LTD - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ORCHID PHARMA LTD FULFORD INDIA/
ORCHID PHARMA LTD
 
P/E (TTM) x 398.8 -0.5 - View Chart
P/BV x 6.2 0.4 1,639.2% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   ORCHID PHARMA LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ORCHID PHARMA LTD
Sep-13
FULFORD INDIA/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs942194 485.6%   
Low Rs45035 1,285.7%   
Sales per share (Unadj.) Rs691.4276.5 250.1%  
Earnings per share (Unadj.) Rs11.5-79.2 -14.5%  
Cash flow per share (Unadj.) Rs15.4-43.5 -35.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.053.9 704.5%  
Shares outstanding (eoy) m3.9070.45 5.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.00.4 243.1%   
Avg P/E ratio x60.7-1.4 -4,200.9%  
P/CF ratio (eoy) x45.3-2.6 -1,719.6%  
Price / Book Value ratio x1.82.1 86.3%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,7148,067 33.7%   
No. of employees `0000.42.8 15.9%   
Total wages/salary Rs m5052,527 20.0%   
Avg. sales/employee Rs Th6,073.06,956.1 87.3%   
Avg. wages/employee Rs Th1,137.4902.5 126.0%   
Avg. net profit/employee Rs Th100.7-1,993.0 -5.1%   
INCOME DATA
Net Sales Rs m2,69619,477 13.8%  
Other income Rs m125407 30.8%   
Total revenues Rs m2,82219,884 14.2%   
Gross profit Rs m-461,103 -4.2%  
Depreciation Rs m152,519 0.6%   
Interest Rs m105,227 0.2%   
Profit before tax Rs m54-6,236 -0.9%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m10-125 -7.7%   
Profit after tax Rs m45-5,580 -0.8%  
Gross profit margin %-1.75.7 -30.4%  
Effective tax rate %17.72.0 880.6%   
Net profit margin %1.7-28.7 -5.8%  
BALANCE SHEET DATA
Current assets Rs m1,73811,014 15.8%   
Current liabilities Rs m54532,060 1.7%   
Net working cap to sales %44.3-108.1 -41.0%  
Current ratio x3.20.3 928.9%  
Inventory Days Days4895 51.1%  
Debtors Days Days434 12.8%  
Net fixed assets Rs m1229,440 0.0%   
Share capital Rs m39705 5.5%   
"Free" reserves Rs m1,4432,043 70.6%   
Net worth Rs m1,4823,800 39.0%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m2,07746,510 4.5%  
Interest coverage x6.7-0.2 -3,477.5%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x1.30.4 310.1%   
Return on assets %2.6-0.8 -343.4%  
Return on equity %3.0-146.9 -2.1%  
Return on capital %4.3-3.7 -115.3%  
Exports to sales %037.9 0.0%   
Imports to sales %24.522.6 108.1%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs m6594,406 15.0%   
Fx inflow Rs m177,513 0.2%   
Fx outflow Rs m6735,649 11.9%   
Net fx Rs m-6561,865 -35.2%   
CASH FLOW
From Operations Rs m901,682 5.4%  
From Investments Rs m105-9,860 -1.1%  
From Financial Activity Rs m-146,644 -0.2%  
Net Cashflow Rs m181-1,535 -11.8%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 4.6 82.6%  
FIIs % 0.1 3.3 3.0%  
ADR/GDR % 0.0 4.6 -  
Free float % 21.2 55.3 38.3%  
Shareholders   4,783 84,811 5.6%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   SANOFI INDIA  TORRENT PHARMA  PLETHICO PHARMA  CIPLA  ABBOTT INDIA  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS